|16th September 2015
We are pleased to announce that Blue Latitude have been reappointed to provide Janssen with strategic support and creative marketing services for their brand teams in the EMEA region. Following this renewed three year contract, we will continue our successful partnership with Janssen, offering our full breadth of services across a wide range of therapy areas. Talking about the partnership, leadership from both companies had the following to say;
The Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g., multiple myeloma and prostate cancer), immunology (e.g., psoriasis), neuroscience (e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes). Driven by a commitment to patients, Janssen develops sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. For their latest news, follow Janssen on Twitter: @JanssenEMEA.
|25th March 2019
March is Myltiple Myeloma Awareness Month, a disease which has personally touched the lives of many people at Blue Latitude. For the rest of the month we have a few events planned to mark our continued commitment to combatting this disease.